Clinical Trial

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-10-21; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2024-02-15
Trial Details
NCT Number NCT04602754
Lead Sponsor EMS
Conditions Dyslipidemia Associated With Type II Diabetes Mellitus
Enrollment 228 participants
Start Date 2023-12-01
Primary Completion 2026-05 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-08